Antibody developed by Dr. Weissman and his colleagues shows promise in a small clinical trial as a safe cancer therapy

Written by Yong Chong

http://med.stanford.edu/news/all-news/2018/10/anti-cd47-cancer-therapy-safe-shows-promise-in-small-trial.html

Yong Chong
Previous

SDRC researchers use zinc to target insulin producing cells
Next

The ISPAD Clinical Practice consensus Guidelines 2018 are now available online